Valute / IMCR
IMCR: Immunocore Holdings plc - American Depositary Shares
32.34
USD
0.03
(0.09%)
Il tasso di cambio IMCR ha avuto una variazione del 0.09% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 31.37 e ad un massimo di 33.00.
Segui le dinamiche di Immunocore Holdings plc - American Depositary Shares. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
IMCR News
- Seeking Alpha Immunocore Holdings plc 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:IMCR)
- Seeking Alpha Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
- Zacks IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
- Zacks Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y
- Zacks Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
- Zacks PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
- Zacks MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
- Zacks Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates
- Zacks Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y
- Zacks Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
- Zacks Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics
- Zacks ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
- Investing Immunocore Holdings earnings missed by $0.02, revenue topped estimates
- Zacks Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles
- Zacks HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
- Zacks BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark
- Zacks RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
- Zacks Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
- Zacks ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises
- Zacks Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
- Zacks JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
- Zacks ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
- Zacks TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line
- Zacks CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption
Intervallo Giornaliero
31.37
33.00
Intervallo Annuale
23.15
39.32
- Chiusura Precedente
- 32.31
- Apertura
- 32.29
- Bid
- 32.34
- Ask
- 32.64
- Minimo
- 31.37
- Massimo
- 33.00
- Volume
- 641
- Variazione giornaliera
- 0.09%
- Variazione Mensile
- -1.88%
- Variazione Semestrale
- 7.76%
- Variazione Annuale
- -8.95%
19 agosto, martedì
12:30
USD
- Agire
- 1.428 M
- Fcst
- 1.287 M
- Prev
- 1.358 M
12:30
USD
- Agire
- 1.354 M
- Fcst
- 1.415 M
- Prev
- 1.393 M
12:30
USD
- Agire
- 5.2%
- Fcst
- 3.2%
- Prev
- 5.9%
12:30
USD
- Agire
- -2.8%
- Fcst
- -1.8%
- Prev
- -0.1%
18:10
USD
- Agire
- Fcst
- Prev